Plasma Cell Myeloma

Primary Site Histology Behavior
C000-C699, C739-C750, C754-C809 9732 <Any value>
C700-C729, C751-C753 9732 3

Notes

9732 Multiple myeloma **Note 1:** The following sources were used in the development of this schema * SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf) * SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/) * Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx * Chapter 82 *Plasma Cell Myeloma and Plasma Cell Disorder*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois. **Note 2:** TNM data elements are not defined for this schema. TNM Stage Group is defined for multiple myeloma only (see Note 3) **Note 3:** The *Revised International Staging System (RISS)* is being used to stage plasma cell myeloma/multiple myeloma (9732). The following variables must be collected at the time of diagnosis for staging: * High Risk Cytogenetics [NAACCR Data Item #3857] * LDH Pretreatment Level [NAACCR Data Item #3932] * Serum Albumin Pretreatment Level [NAACCR Data Item #3930] * Serum Beta-2 Microglobulin Pretreatment Level [NAACCR Data Item #3931]

Data Items

Name Default Value Used in Derivation NAACCR Item Required By Metadata
Year of Diagnosis No NAACCR #390
dateOfDiagnosis 		None
Primary Site Yes NAACCR #400
primarySite 		None
Histology Yes NAACCR #522
histologicTypeIcdO3 		None
Behavior Yes NAACCR #523
behaviorCodeIcdO3 		None
Schema Discriminator 1 0 Yes NAACCR #3926
schemaDiscriminator1 		All SSDI
Tumor Size Clinical 999 No NAACCR #752
tumorSizeClinical 		None
Tumor Size Pathological 999 No NAACCR #754
tumorSizePathologic 		None
Tumor Size Summary 999 No NAACCR #756
tumorSizeSummary 		None
Regional Nodes Positive 99 No NAACCR #820
regionalNodesPositive 		None
Regional Nodes Examined 99 No NAACCR #830
regionalNodesExamined 		None
LVI 8 No NAACCR #1182
lymphVascularInvasion 		None
EOD Primary Tumor 999 Yes NAACCR #772
eodPrimaryTumor 		None
EOD Regional Nodes 888 Yes NAACCR #774
eodRegionalNodes 		None
EOD Mets 88 Yes NAACCR #776
eodMets 		None
SS2018 No NAACCR #764
summaryStage2018 		None
Grade Clinical 8 No NAACCR #3843
gradeClinical 		CCCR/Canada
COC
NPCR
SEER		 SSDI
Grade Pathological 8 No NAACCR #3844
gradePathological 		CCCR/Canada
COC
NPCR
SEER		 SSDI
Grade Post Therapy Clin (yc) No NAACCR #1068
gradePostTherapyClin 		COC
NPCR
SEER		 SSDI
Grade Post Therapy Path (yp) No NAACCR #3845
gradePostTherapy 		CCCR/Canada
COC
NPCR
SEER		 SSDI
Serum Beta-2 Microglobulin Pretreatment Level 9 No NAACCR #3931
serumBeta2MicroglobulinPretxLvl 		CCCR/Canada
COC
SEER		 SSDI
Serum Albumin Pretreatment Level 9 No NAACCR #3930
serumAlbuminPretreatmentLevel 		CCCR/Canada
COC
SEER		 SSDI
High Risk Cytogenetics 9 No NAACCR #3857
highRiskCytogenetics 		CCCR/Canada
COC
SEER		 SSDI
LDH Level 9 No NAACCR #3869
ldhPretreatmentLevel 		CCCR/Canada
COC
SEER		 SSDI

Initial Context

Staging Methods

Expand All | Collapse All

Summary Stage 2018

Start

  2. EOD Primary Tumor
  3. ss2018_t

Next Step

  2. EOD Regional Nodes
  3. ss2018_n

Next Step

  2. EOD Mets
  3. ss2018_m

Next Step

  2. Summary Stage - T only
  3. ss2018_derived

End

Outputs

Name Default Value Description NAACCR Item Metadata
Schema ID 00821 NAACCR #3800
schemaId 		None
Derived Version {{ctx_alg_version}} None None
Derived Summary Stage 2018 9 NAACCR #762
derivedSummaryStage2018 		None